Protein-Losing Enteropathy Resolved by Helicobacter pylori Eradication
Bruno Sousa, Rosa Alves, Catarina Pestana Santos, Tiago Judas
Department of Internal Medicine, Hospital Garcia de Orta, Almada, Lisbon, Portugal
Doi: 10.12890/2022_003312 - European Journal of Case Reports in Internal Medicine - © EFIM 2022
Received: 21/03/2021
Accepted: 19/04/2022
Published: 26/05/2022

How to cite this article: Sousa B, Alves R, Pestana Santos C, Judas T. Protein-losing enteropathy resolved by Helicobacter pylori eradication. EJCRIM 2022;9 doi:10.12890/2022_003312.

Conflicts of Interests: The authors declare there are no competing interests.
This article is licensed under a Commons Attribution Non-Commercial 4.0 License

ABSTRACT

Protein-losing enteropathy (PLGE) is an uncommon condition with a multifactorial origin, that is characterized by excessive loss of serum proteins into the gastrointestinal tract, resulting in hypoproteinaemia and oedema.
The authors present the case of a 24-year-old man admitted to hospital for a 2-month history of lower extremity oedema and diarrhoea with a secretory pattern. Blood analysis revealed hypoalbuminaemia and iron deficiency anaemia. Liver disease and severe proteinuria were excluded as possible aetiologies. Upper gastrointestinal endoscopy revealed signs of chronic Helicobacter pylori gastritis. After completion of H. pylori eradication, the patient had complete resolution of clinical and laboratory abnormalities.
The results suggest the need to consider less frequent aetiologies for peripheral oedema and hypoproteinaemia, such as PLGE, especially those caused by prevalent bacterial agents like H. pylori.

LEARNING POINTS

KEYWORDS

Protein losing-enteropathy, oedema, hypoalbuminaemia, Helicobacter pylori

INTRODUCTION

Protein-losing enteropathy (PLGE) is an uncommon condition characterized by an excessive loss of serum proteins into the gastrointestinal tract, resulting in hypoproteinaemia and generalized oedema. It should be considered when other causes of hypoproteinaemia (malnutrition, liver disease, severe proteinuria) have been excluded [1]. It is secondary to a variety of diseases, including bacterial and viral infections.

CASE DESCRIPTION

A 24-year-old Caucasian man was admitted to hospital for investigation of a 2-month history of bilateral lower limb and testicular swelling and diarrhoea with a secretory pattern. He had a history of pulmonary embolism and type 1 diabetes, and was chronically medicated with insulin and rivaroxaban. Furosemide had recently been added to control oedema, with no response.
Physical examination confirmed marked oedema of the lower limbs with Godet’s sign and of the scrotum (Fig. 1). No physical signs of pleural effusion or ascites were detected.
Laboratory investigations identified iron deficiency anaemia and severe hypoproteinaemia with concomitant hypoalbuminaemia. Urine analysis was negative for proteinuria. A 24-hour urine sample was also collected and confirmed the absence of proteinuria. An electrocardiogram showed sinus rhythm and normal tracing. Chest radiography was unremarkable. Cardiac disease was ruled out by transthoracic echocardiography. Liver disease was also considered and an abdominal ultrasound was performed with evidence of slight hepatomegaly but with no signs of cirrhosis or portal hypertension. Chronic viral hepatitis (hepatitis C and B) and other causes of chronic liver disease were also excluded, namely Wilson's disease, haemochromatosis, alpha 1 antitrypsin deficiency, primary biliary cirrhosis and autoimmune hepatitis. Other viral diseases were also considered and eventually ruled out by serological studies (CMV, EBV and HIV 1/2). In light of the clinical history and laboratory findings, after exclusion of other causes of hypoproteinaemia and oedema, PLGE was the most likely diagnosis. To investigate this hypothesis, the patient underwent upper gastrointestinal endoscopy (Fig. 2) that ultimately revealed large and hyperaemic mucosal folds confined to the gastric antrum. Histological analysis showed signs of chronic gastritis of the antrum associated with Helicobacter pylori infection.

Figure 1 (click to enlarge)

Figure 2 (click to enlarge)

Figure 1. Patient’s marked oedema of the lower limbs with Godet’s sign
Figure 2. Endoscopic image from the gastric antrum revealing large and hyperaemic mucosal folds confined to the gastric antrum

TStool was also collected for parasitological and bacterial analysis, which was negative.
Based on these results, treatment with esomeprazole, amoxicillin and clarithromycin to eradicate H. pylori infection was instituted. Clinical improvement was noted with rapid resolution of diarrhoea and progressive improvement and eventual resolution of oedema a few weeks later. Anaemia and hypoproteinaemia also spontaneously resolved after treatment.
The final diagnosis of PLGE secondary to H. pylori gastritis was established.

DISCUSSION

The hallmark of PLGE is protein leakage from the gastrointestinal tract, leading to peripheral oedema and rarely to progressive dyspnoea or painless abdominal distention due to symptomatic pleural effusions or ascites [2].
This protein leakage can occur via one of three possible mechanisms: increased capillary permeability (caused by autoimmune diseases, eosinophilic gastroenteropathy, giant hypertrophic and lymphocytic gastritis, and bacterial and parasitic infections) [2, 3]; increased lymphatic pressure (caused by lymphatic obstruction, congenital abnormalities of the lymphatic system or other disorders that result in increased lymphatic pressure); and breakdown of the mucosal barrier, such as mucosal erosion or ulcers, allowing free passage of interstitial protein into the intestine [3]. Among the bacterial causes, an association has been recognized since the early 1990s between PLGE and H. pylori infection, but with few cases reported [3, 4]. Endoscopic findings of PLGE with H. pylori infection mainly consist of Ménétrier’s disease, diffuse varioliform gastritis, or rarely cap polyposis [3, 4]. Ménétrier’s disease has been previously reported to be associated with H. pylori infection. One of the first retrospective studies describing the connection between H. pylori and Ménétrier’s disease showed an association between hypertrophic gastropathy and H. pylori infection in more than 90% of cases [5]. Other previous reports have showed that the eradication of H. pylori completely resolved PLGE in Ménétrier’s disease, and also in cases of hypertrophic lymphocytic gastritis or erosive gastritis associated with H. pylori infection [3, 4 ,6].
The mechanisms by which H. pylori infection causes PLGE are not completely understood [6], but in Ménétrier’s disease, the presence of giant folds and wider tight junctions between cells may lead to increased permeability and protein-rich exudates in the stomach [7]. A recent report showed PLGE due to H. pylori infection without giant rugal folds, erosion or polyposis [3], suggesting a defect in the epithelial tight junction caused by H. pylori infection in the intestine polyposis[3, 4].
In our case, oedema and hypoproteinaemia started to resolve a few weeks after the institution of the eradication protocol, strongly suggesting a link between the infection and symptoms. Also, despite the endoscopic findings of large and hyperaemic mucosal folds, they were not related to classic Ménétrier’s disease, but instead to chronic gastritis secondary to H. pylori infection.
Some studies show a relationship between chronic H. pylori gastritis and changes in tight junctions associated with the expression and high production of hepatocyte growth factor [8]. These induced tight junction changes could lead to protein loss and consequent oedema (by hypoalbuminemia), and even be responsible for reduced iron absorption and iron deficiency anaemia (present in our patient).
The present case emphasizes the need to consider less frequent aetiologies for peripheral oedema and hypoproteinaemia, such as PLGE, especially those caused by prevalent bacterial agents in the general population, like H. pylori. This close association also suggests that H. pylori eradication is warranted in patients with PLGE accompanied by H. pylori infection.

References
  1. Elli L, Topa M, Riomondi A. Protein losing enteropathy. Curr Opin Gastroenterol 2020;36(3):238–244.
  2. Umar SB, DiBaise JK. Protein-losing enteropathy: case illustrations and clinical review. Am J Gastroenterol 2010 Jan;105(1):43–49.
  3. Yoshioka K, Kishibuchi M, Takada K. Protein losing gastroenteropathy due to Helicobacter pylori infection without giant rugal folds, erosion or polyposis. BMJ Case Rep 2019;12:e230870.
  4. Badov D, Lambert JR, Finlay M, Balazs ND. Helicobacter pylori as a pathogenic factor in Ménétrier’s disease. Am J Gastroenterol 1998;93:1976–1979.
  5. Stolte M, Bätz C, Eidt S. Giant fold gastritis--a special form of Helicobacter pylori associated gastritis. Z Gastroenterol 1993 May;31(5):289–293.
  6. Groisman GM, George J, Berman D, Harpaz N. Resolution of protein-losing hypertrophic lymphocytic gastritis with therapeutic eradication of Helicobacter pylori. Am J Gastroenterol 1994;89:1548–1551.
  7. Toubia N, Schubert ML. Menetrier’s disease. Curr Treat Options Gastroenterol 2008;11:103–118.
  8. Ishikawa T, Ando T, Obayashi H, Nakabe N, Okita M, Isozaki Y, et al. Helicobacter pylori isolated from a patient with Ménétrier's disease increases hepatocyte growth factor mRNA expression in gastric fibroblasts: comparison with Helicobacter pylori isolated from other gastric diseases. Dig Dis Sci 2008 Jul;53(7):1785–1791.